Zota Health Care share news, announcements and annual reports
NSE: ZOTAPharmaceuticals & BiotechnologySmall Cap
Zota Health Care LImited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2017 · Issue price ₹198.25
Last close ₹1,271.10down ₹8.90 (0.70%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹1,280.00.
28 Oct: open ₹1,288.00, high ₹1,316.60, low ₹1,259.40
52-week range of traded prices to 28 Oct 2026
₹1,022.00Low, 2 Sep 2026₹1,740.00High, 21 Nov 2025
- Next results date: the board meets on 28 Oct 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,402 Cr838th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −24.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −16.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 36,58447.6% delivered
Zota Health Care disputes and clarifications
12 filed, newest first.
Apr 2026
Jan 2026
13 Jan · Legal
Exchange has sought clarification from Zota Health Care LImited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Jul 2025
2 Jul · Legal
The exchange asked on 1 Jul 2025
Jul 2021
14 Jul · Legal
Exchange has sought clarification from Zota Health Care LImited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Apr 2020
28 Apr · Legal
Exchange has sought clarification from Zota Health Care Limited with respect to announcement dated 28-Apr-2020, regarding 'Launched new product with the name COROVYL for Viral Infection'.".The response of the Company is awaited.
Jul 2019
22 Jul · Legal
Exchange has sought clarification from Zota Health Care LImited with respect to announcement dated 10-Jun-2019, regarding that Board of Directors of the Company in its meeting held on June 10, 2019 have recommended the issuance of fully paid Bonus Share in the ratio of 4:10 [i.e. 4 (Four) fully paid up equity shares for every 10 (Ten) equity shares held], subject to the shareholder's approval.". On basis of above the Company is required to clarify following: 1. Estimated date by which such bonus shares would be credited/dispatched.2. Whether the figures are audited;3. Free reserves and/ or share premium available for capitalization and the date as on which such balance is available;4. Free reserves and/ or share premium required for implementing the bonus issue;5. Details of share capital - pre and post bonus issue;6. Whether bonus is out of free reserves created out of profits or share premium account;The response of the Company is awaited.
Jul 2017
12 Jul · Legal
Exchange has sought clarification from Zota Health Care LImited with respect to announcement dated 12-Jul-2017, regarding Outcome of Board Meeting held on July 12, 2017 Appointment of Auditor.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.